Principal QM Research Scientist / Engineer

Posted:
7/23/2024, 6:33:03 AM

Location(s):
California, United States ⋅ New York, New York, United States ⋅ Burlingame, California, United States ⋅ New York, United States

Experience Level(s):
Expert or higher ⋅ Senior

Field(s):
AI & Machine Learning

Workplace Type:
Hybrid

Genesis Therapeutics is bringing together a world-class computational team to build out the industry's fastest and most accurate small molecule property predictions by combining the power of machine learning and physics-based methods. We are seeking QM experts to help build state of the art molecular force fields and machine learned potentials that will be foundational to our computational platform.
Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.
 
Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets. 
 
The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022, with a $20M upfront payment and a $670M total deal size), and Genentech (signed in 2020).
We raised a $200M series B in August 2023, and have raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. 
 
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
 
 
 
Finding the best talent is our top priority at Genesis Therapeutics. If you are interested in potential partnership on recruitment, please reach out to [email protected].
 

Genesis Therapeutics

Website: https://www.genesistherapeutics.ai/

Headquarter Location: South San Francisco, California, United States

Employee Count: 11-50

Year Founded: 2019

IPO Status: Private

Last Funding Type: Series B

Industries: Artificial Intelligence (AI) ⋅ Biotechnology ⋅ Information Technology